After Canary submitted an ETF application related to Projective, INJ re-enters the market. According to the article, the application reinforced the market ' s expectation that Injective would receive institutional attention and also led traders to reassess the subsequent movement of the currency.
Product design to pledge proceeds
According to the application, the proposed fund code is INJS. While holding INJ, the product will also use part of the hold to pledge to obtain a network incentive. This means that investors may not only have access to currency price openings, but may also share in collateral gains.
It was also mentioned that the product would be hosted by BitGo and would use a cash requisition and foreclosure mechanism. In response to the release cycle of Projective, a liquidity reserve was also set up in the programme to support investors in their redemption.
Market focus shifted to institutional narratives
Beyond Bitcoin and Ethera, traditional institutions have recently been focusing on more digital assets. According to the article, the Inject differs from some of the same Layer 1 projects by covering DeFi, derivative infrastructure, tokenized assets and cross-chain applications.
If the related ETF moves smoothly, the visibility of Inject among traditional investors may increase further. For part of the funding, the regulated form of the product, coupled with the pledge-proceeding design, was the main reason for interest in the application.
INJ Price Concern $4 versus $5.2
In terms of price performance, INJ is still in the recovery phase following the earlier reversals. According to the article, there have been many instances of support in the vicinity of the United States dollar, and recent purchases have been concentrated in this area, making it a more critical defensive position at present.
Short-line resistance above is around US$ 5.2. If this position is breached, the price may be further tested for the $6 area. On top of that, $7 to $7.5 is considered the next major discharge area.
If INJ continues to hold up to $4, the market may continue to observe whether it has the opportunity to advance to $5.5 and $6. This ETF application has allowed Inject to return to the investor watch list, and the follow-up focus will be on whether the institution expects to be able to turn into a continuous buyout.